Yahoo · Oct 23, 2026
Should Invesco S&P Ultra Dividend Revenue ETF (RDIV) Be on Your Investing Radar?
Style Box ETF report for RDIV

NYSE · IVZ
Financial Services · Asset Management
$28.43
Up+$0.32 (+1.13%)
Updated Oct 28, 2026, 1:40 PM
SID Score
6.4/10
Composite research score
Smart Money
58/100
Neutral
Price performance · IVZ
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 27, 2026
IVZ closed at $28.43 after 21 trading sessions, down 6.54% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | $28.55 | $29.20 | $28.37 | $28.43 | 6.75M |
| Oct 26, 2026 | $28.28 | $28.84 | $28.065 | $28.53 | 8.48M |
| Oct 23, 2026 | $28.41 | $28.565 | $28.02 | $28.06 | 8.26M |
| Oct 22, 2026 | $28.72 | $29.38 | $28.51 | $28.79 | 6.08M |
| Oct 21, 2026 | $29.22 | $29.44 | $27.72 | $29.25 | 5.29M |
| Oct 20, 2026 | $28.17 | $29.20 | $28.17 | $28.78 | 3.97M |
| Oct 19, 2026 | $28.30 | $28.66 | $28.11 | $28.29 | 4.06M |
| Oct 16, 2026 | $28.94 | $29.22 | $27.95 | $28.20 | 5.04M |
| Oct 15, 2026 | $27.93 | $28.81 | $27.18 | $28.80 | 5.34M |
| Oct 14, 2026 | $28.54 | $28.76 | $27.625 | $27.93 | 4.13M |
| Oct 13, 2026 | $29.40 | $29.515 | $28.625 | $28.92 | 2.76M |
| Oct 12, 2026 | $29.51 | $29.64 | $29.07 | $29.26 | 5.18M |
| Oct 9, 2026 | $29.95 | $30.01 | $29.37 | $29.51 | 5.03M |
| Oct 8, 2026 | $30.09 | $30.4205 | $29.865 | $30.09 | 3.92M |
| Oct 7, 2026 | $30.01 | $30.52 | $29.86 | $30.50 | 4.45M |
| Oct 6, 2026 | $30.73 | $30.855 | $30.30 | $30.38 | 4.09M |
| Oct 5, 2026 | $30.67 | $30.755 | $30.07 | $30.50 | 3.65M |
| Oct 2, 2026 | $30.90 | $31.2855 | $30.435 | $30.66 | 3.88M |
| Oct 1, 2026 | $30.14 | $30.67 | $29.75 | $30.42 | 5.07M |
| Sep 30, 2026 | $30.41 | $30.54 | $30.145 | $30.16 | 4.13M |
| Sep 29, 2026 | $30.37 | $30.59 | $29.965 | $30.42 | 3.99M |
The latest Smart Investors Daily articles mentioning IVZ.
Company
Market Activity
Research & News
IVZ research
Company profile and research snapshot.
Invesco provides investment-management services to retail (70% of managed assets) and institutional (30%) clients. At the end of September 2025, the firm had $2.125 trillion in assets under management spread among its equity (60% of AUM), balanced (3%), fixed-income (21%), alternative investment (6%), and money market (10%) operations. Passive products account for 47% of Invesco's total AUM. Invesco's US retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside of North America, with 31% of its AUM sourced from Europe, Africa, and the Middle East (16%) and Asia (15%).
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 22, 2026 | Morgan Stanley | Equal-Weight | — |
| Oct 13, 2026 | BMO Capital | Outperform | — |
| Oct 12, 2026 | TD Cowen | Buy | — |
| Oct 9, 2026 | Evercore ISI Group | In-Line | — |
| Oct 9, 2026 | RBC Capital | Outperform | — |
No generated briefing is available yet.
Yahoo · Oct 23, 2026
Style Box ETF report for RDIV
Yahoo · Oct 23, 2026
We share with you three top-ranked Invesco mutual funds. Each has earned a Zacks Mutual Fund Rank #1.
Yahoo · Oct 22, 2026
Invesco is preparing to report September-quarter results, with consensus pointing to higher earnings of $0.74 per share on revenue of $1.39b compared with the prior year. The mix of stronger expected fundamentals and slightly more cautious analyst estimate revisions highlights how investors are weighing business momentum against potential execution pressures. Next, the focus shifts to how Invesco's expected earnings uplift and softer analyst tone could reshape the broader investment...
Benzinga · Oct 22, 2026
Morgan Stanley analyst Michael Cyprys maintains Invesco (NYSE:IVZ) with a Equal-Weight and raises the price target from $31 to $32.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning IVZ.